Clinical Trials Directory

Trials / Completed

CompletedNCT00048854

Antidepressant Treatment for Premenstrual Syndrome and Premenstrual Dysphoric Disorder

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
66 (actual)
Sponsor
Yale University · Academic / Other
Sex
Female
Age
18 Years – 48 Years
Healthy volunteers
Not accepted

Summary

This study will determine whether characteristics of women with Premenstrual Syndrome influence response to treatment with serotonin reuptake inhibitors and whether SRIs can alleviate premenstrual symptoms.

Detailed description

Moderate to severe premenstrual disturbances afflict up to 20 percent of women. Studies have shown the use of serotonin reuptake inhibitors (SRIs) during the luteal phase of the menstrual cycle to be effective in improving symptoms in women with premenstrual dysphoric disorder (PMDD). Unfortunately, SRI treatment has only been evaluated in controlled clinical trials, and evidence suggests that patients in these clinical trials are not representative of women commonly seen in clinical practice. Thus, the real-world feasibility of intermittent dosing is questionable. Patients in this study receive sertraline (Zoloft) during the luteal phase of their menstrual cycle every month for 6 months. The dose may be modified based on structured interviews with the patients. Assessments include questionnaires and interviews which take place at study start, at midpoint, and at the end of the study.

Conditions

Interventions

TypeNameDescription
DRUGSertralinePatients who meet study criteria will be given 50 mg per day of sertraline to be taken an estimated 2 weeks before menstruation.
OTHERTreatment as usual (TAU)At the TAU baseline visit, patients will be told of their diagnosis of PMS/PMDD. Those patients who decide to seek treatment outside of the study protocol or do not wish to seek treatment will be asked to participate in the TAU part of this protocol. Patients in TAU will be contacted monthly to obtain monthly information about how they have been feeling (blinded ratings) using the study measures.

Timeline

Start date
2001-09-01
Primary completion
2007-06-01
Completion
2008-01-01
First posted
2002-11-13
Last updated
2016-01-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00048854. Inclusion in this directory is not an endorsement.